Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

SGO1 is involved in the DNA damage response in MYCN-amplified neuroblastoma cells

View through CrossRef
AbstractShugoshin 1 (SGO1) is required for accurate chromosome segregation during mitosis and meiosis; however, its other functions, especially at interphase, are not clearly understood. Here, we found that downregulation of SGO1 caused a synergistic phenotype in cells overexpressing MYCN. Downregulation of SGO1 impaired proliferation and induced DNA damage followed by a senescence-like phenotype only in MYCN-overexpressing neuroblastoma cells. In these cells, SGO1 knockdown induced DNA damage, even during interphase and this effect was independent of cohesin. Furthermore, MYCN-promoted SGO1 transcription and SGO1 expression tended to be higher in MYCN- or MYC-overexpressing cancers. Together, these findings indicate that SGO1 plays a role in the DNA damage response in interphase. Therefore, we propose that SGO1 represents a potential molecular target for treatment of MYCN-amplified neuroblastoma.
Title: SGO1 is involved in the DNA damage response in MYCN-amplified neuroblastoma cells
Description:
AbstractShugoshin 1 (SGO1) is required for accurate chromosome segregation during mitosis and meiosis; however, its other functions, especially at interphase, are not clearly understood.
Here, we found that downregulation of SGO1 caused a synergistic phenotype in cells overexpressing MYCN.
Downregulation of SGO1 impaired proliferation and induced DNA damage followed by a senescence-like phenotype only in MYCN-overexpressing neuroblastoma cells.
In these cells, SGO1 knockdown induced DNA damage, even during interphase and this effect was independent of cohesin.
Furthermore, MYCN-promoted SGO1 transcription and SGO1 expression tended to be higher in MYCN- or MYC-overexpressing cancers.
Together, these findings indicate that SGO1 plays a role in the DNA damage response in interphase.
Therefore, we propose that SGO1 represents a potential molecular target for treatment of MYCN-amplified neuroblastoma.

Related Results

Abstract 3036: ALK protein expression and its prognostic significance in MYCN non amplified neuroblastoma
Abstract 3036: ALK protein expression and its prognostic significance in MYCN non amplified neuroblastoma
Abstract Anaplastic lymphoma kinase (ALK) point mutations (within the kinase domain), gene amplification and protein overexpression are identified (8-14%) both in fa...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Abstract 1678: Single-cell landscape of the TH-MYCN neuroblastoma mouse model
Abstract 1678: Single-cell landscape of the TH-MYCN neuroblastoma mouse model
Abstract Background and aims: Neuroblastoma (NB) is the most common and deadly malignancy of infancy. It is an embryonal neuroendocrine tumor arising from the neural...
MRE11 inhibition highlights a replication stress-dependent vulnerability of MYCN-driven tumors
MRE11 inhibition highlights a replication stress-dependent vulnerability of MYCN-driven tumors
AbstractMRE11 is a component of the MRE11/RAD50/NBS1 (MRN) complex, whose activity is essential to control faithful DNA replication and to prevent accumulation of deleterious DNA d...
Exploration of novel therapeutic targets in neuroblastoma
Exploration of novel therapeutic targets in neuroblastoma
<p dir="ltr">Neuroblastoma is a malignancy of the sympathetic nervous system occurring in early childhood. It accounts for approximately 6% of all childhood cancers and is a ...
Exploration of novel therapeutic targets in neuroblastoma
Exploration of novel therapeutic targets in neuroblastoma
<p dir="ltr">Neuroblastoma is a malignancy of the sympathetic nervous system occurring in early childhood. It accounts for approximately 6% of all childhood cancers and is a ...
Abstract 4374: The role of glycine decarboxylase in neuroblastoma
Abstract 4374: The role of glycine decarboxylase in neuroblastoma
Abstract Neuroblastoma is the most common cancer in infants. While the low and intermediate risk groups of neuroblastoma patients have ≥90% five-year-survival rates,...
A combination of PARP and CHK1 inhibitors efficiently antagonizes MYCN-driven tumors
A combination of PARP and CHK1 inhibitors efficiently antagonizes MYCN-driven tumors
AbstractMYCN drives aggressive behavior and refractoriness to chemotherapy, in several tumors. Since MYCN inactivation in clinical settings is not achievable, alternative vulnerabi...

Back to Top